Engineered probiotics modulate the endocannabinoid system

Abstract Butyrate is a key microbial metabolite known to enhance host metabolic processes by reducing blood glucose levels and promoting energy metabolism, thereby potentially suppressing the risk of developing metabolic syndrome. In this study, we examined the activity of butyrate on modulating the endocannabinoid system, which regulates food intake and energy metabolism. Furthermore, we genetically engineered probiotics to produce butyrate to investigate their effects on the endocannabinoid system. Our study shows that the engineered probiotics exerted antagonistic effects on the endocannabinoid system by downregulating and upregulating the endocannabinoid-synthesizing and -degrading enzyme expression, respectively. Our results suggest that butyrate can modulate the endocannabinoid system, and incorporation of butyrate-producing bacteria into the gut microbiota can potentially aid in re-establishing homeostatic metabolic processes and alleviating metabolic syndrome.

• Publication year

  2021

• Venue

  Biotechnology Notes

• Publication date

  Unknown publication date

• Fields of study

  Biology, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/j.biotno.2021.08.001
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineering commensal bacteria to rewire host-microbiome interactions.

  2020cited by this paper
• Engineering probiotics for therapeutic applications: recent examples and translational outlook.

  2020cited by this paper
• Biosensing in Smart Engineered Probiotics

  2019cited by this paper
• Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes

  2018cited by this paper
• Engineering bacteria for diagnostic and therapeutic applications

  2018cited by this paper
• Synthetic Biology and the Gut Microbiome

  2018cited by this paper
• Endocannabinoids in the gastrointestinal tract.

  2016cited by this paper
• Metabolic engineering of Saccharomyces cerevisiae for the overproduction of short branched-chain fatty acids.

  2016cited by this paper
• Endocannabinoids in the Gut

  2016cited by this paper
• Dietary Gut Microbial Metabolites, Short-chain Fatty Acids, and Host Metabolic Regulation

  2015cited by this paper
• The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease.

  2015cited by this paper
• The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

  2014cited by this paper
• Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.

  2014cited by this paper
• Butyrate production in engineered Escherichia coli with synthetic scaffolds.

  2013cited by this paper
• The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism

  2013cited by this paper
• Conserved Shifts in the Gut Microbiota Due to Gastric Bypass Reduce Host Weight and Adiposity

  2013cited by this paper
• Dietary Linoleic Acid Elevates Endogenous 2-AG and Anandamide and Induces Obesity

  2012cited by this paper
• Diet-Induced Dysbiosis of the Intestinal Microbiota and the Effects on Immunity and Disease

  2012cited by this paper
• Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5

  2010cited by this paper
• The endocannabinoid system links gut microbiota to adipogenesis

  2010cited by this paper
• Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

  2009cited by this paper
• A modified Western blot protocol for enhanced sensitivity in the detection of a membrane protein.

  2009cited by this paper
• The Effect of Diet on the Human Gut Microbiome: A Metagenomic Analysis in Humanized Gnotobiotic Mice

  2009cited by this paper
• Mechanisms underlying the resistance to diet-induced obesity in germ-free mice

  2007cited by this paper
• The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

  2006cited by this paper
• An obesity-associated gut microbiome with increased capacity for energy harvest

  2006cited by this paper
• Microbial ecology: Human gut microbes associated with obesity

  2006cited by this paper
• Obesity alters gut microbial ecology.

  2005cited by this paper
• Host-Bacterial Mutualism in the Human Intestine

  2005cited by this paper
• In vitro fermentation characteristics of a mixture of Raftilose and guar gum by human faecal bacteria

  2005cited by this paper
• The gut microbiota as an environmental factor that regulates fat storage.

  2004cited by this paper
• Lipopolysaccharide Induces Anandamide Synthesis in Macrophages via CD14/MAPK/Phosphoinositide 3-Kinase/NF-κB Independently of Platelet-activating Factor*

  2003cited by this paper
• One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products.

  2000cited by this paper
• Formation of short-chain fatty acids from different dietary fibre sources in the rat caecum.

  1995cited by this paper

• Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective

  2025cites this paper
• Design of a Continuous GAA-Producing Probiotic as a Potential Mitigator of the Effects of Sleep Deprivation.

  2025cites this paper
• The endocannabinoidome–gut microbiome–brain axis as a novel therapeutic target for autism spectrum disorder

  2025cites this paper
• The short-chain fatty acid acetate modulates orexin/hypocretin neurons: A novel mechanism in gut-brain axis regulation of energy homeostasis and feeding.

  2024cites this paper
• Utilization of diverse probiotics to create human health promoting fatty acids: A review.

  2024cites this paper
• Advancements in Microbial Cell Engineering for Benzylisoquinoline Alkaloid Production.

  2024cites this paper
• Characterizing a Propionate Sensor in E. coli Nissle 1917.

  2023cites this paper
• Engineering of a probiotic yeast for the production and secretion of medium-chain fatty acids antagonistic to an opportunistic pathogen Candida albicans

  2023cites this paper
• The emerging role of the endocannabinoidome-gut microbiome axis in eating disorders.

  2023cites this paper
• Engineering bacteria to modulate host metabolism

  2023cites this paper
• The Endocannabinoids-Microbiota Partnership in Gut-Brain Axis Homeostasis: Implications for Autism Spectrum Disorders

  2022cites this paper
• An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in in vitro Inflammatory Bowel Disease Models

  2022cites this paper
• Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies

  2022cites this paper